These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 9271429)
1. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Ravichandran KS; Zhou MM; Pratt JC; Harlan JE; Walk SF; Fesik SW; Burakoff SJ Mol Cell Biol; 1997 Sep; 17(9):5540-9. PubMed ID: 9271429 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566 [TBL] [Abstract][Full Text] [Related]
4. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site. van der Geer P; Wiley S; Pawson T Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378 [TBL] [Abstract][Full Text] [Related]
5. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner. Farooq A; Plotnikova O; Zeng L; Zhou MM J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694 [TBL] [Abstract][Full Text] [Related]
6. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo. Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723 [TBL] [Abstract][Full Text] [Related]
7. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor. O'Bryan JP; Lambert QT; Der CJ J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397 [TBL] [Abstract][Full Text] [Related]
8. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc. Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373 [TBL] [Abstract][Full Text] [Related]
9. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391 [TBL] [Abstract][Full Text] [Related]
10. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking. Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245 [TBL] [Abstract][Full Text] [Related]
11. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769 [TBL] [Abstract][Full Text] [Related]
12. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. Lamkin TD; Walk SF; Liu L; Damen JE; Krystal G; Ravichandran KS J Biol Chem; 1997 Apr; 272(16):10396-401. PubMed ID: 9099679 [TBL] [Abstract][Full Text] [Related]
13. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction. Yajnik V; Blaikie P; Bork P; Margolis B J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619 [TBL] [Abstract][Full Text] [Related]
14. The PI/PTB domain: a new protein interaction domain involved in growth factor receptor signaling. Margolis B J Lab Clin Med; 1996 Sep; 128(3):235-41. PubMed ID: 8783629 [TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the Numb phosphotyrosine-binding domain using site-directed mutagenesis. Yaich L; Ooi J; Park M; Borg JP; Landry C; Bodmer R; Margolis B J Biol Chem; 1998 Apr; 273(17):10381-8. PubMed ID: 9553095 [TBL] [Abstract][Full Text] [Related]
16. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a physical association between the Shc-PTB domain and the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor. Pratt JC; Weiss M; Sieff CA; Shoelson SE; Burakoff SJ; Ravichandran KS J Biol Chem; 1996 May; 271(21):12137-40. PubMed ID: 8647804 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein. Li SC; Lai KM; Gish GD; Parris WE; van der Geer P; Forman-Kay J; Pawson T J Biol Chem; 1996 Dec; 271(50):31855-62. PubMed ID: 8943228 [TBL] [Abstract][Full Text] [Related]
19. Tyr-317 phosphorylation increases Shc structural rigidity and reduces coupling of domain motions remote from the phosphorylation site as revealed by molecular dynamics simulations. Suenaga A; Kiyatkin AB; Hatakeyama M; Futatsugi N; Okimoto N; Hirano Y; Narumi T; Kawai A; Susukita R; Koishi T; Furusawa H; Yasuoka K; Takada N; Ohno Y; Taiji M; Ebisuzaki T; Hoek JB; Konagaya A; Kholodenko BN J Biol Chem; 2004 Feb; 279(6):4657-62. PubMed ID: 14613932 [TBL] [Abstract][Full Text] [Related]
20. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]